Cargando…
A clinical study about contrast nephropathy: Risk factors and the role of beta blockers
OBJECTIVE: There is still a group of patient that have unpredictable risk for the development of contrast nephropathy (CN). There is also an effort to find more effficient strategies to prevent CN. Carvedilol, metoprolol and nebivolol seem to have theoretical potentials for the prevention of CN. In...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Kare Publishing
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337060/ https://www.ncbi.nlm.nih.gov/pubmed/25333980 http://dx.doi.org/10.5152/akd.2014.5304 |